VOLULYTE 6% 60mg / 4.63mg / 6.02mg / 0.3mg / 0.3mg / ml solution for infusion medication leaflet

B05AA07 hydroxyethyl starch + sodium acetate trihydrate + sodium chloride + potassium chloride + magnesium chloride hexahydrate • Blood and blood forming organs | Blood and related products | Blood substitutes and plasma protein fractions

This combination of hydroxyethyl starch, sodium acetate trihydrate, sodium chloride, potassium chloride, and magnesium chloride hexahydrate is used as an infusion solution for plasma volume expansion and correction of electrolyte imbalances. Hydroxyethyl starch acts as a plasma expander, while the electrolytes help maintain electrolyte balance.

The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for signs of overdose or electrolyte imbalances.

Side effects may include injection site reactions, electrolyte imbalances, or allergic reactions. In rare cases, renal failure or anaphylactic reactions may occur.

This combination is not recommended for patients with severe renal impairment, hypervolemia, or hypersensitivity to any of the components.

General data about VOLULYTE 6% 60mg / 4.63mg / 6.02mg / 0.3mg / 0.3mg / ml

Substance: hydroxyethyl starch + sodium acetate trihydrate + sodium chloride + potassium chloride + magnesium chloride hexahydrate

Date of last drug list: 01-05-2018

Commercial code: W54129014

Concentration: 60mg / 4.63mg / 6.02mg / 0.3mg / 0.3mg / ml

Pharmaceutical form: solution for infusion

Quantity: 10

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FRESENIUS KABI DEUTSCHLAND GMBH - GERMANIA

Holder: FRESENIUS KABI ROMANIA S.R.L. - ROMANIA

Number: 10443/2017/14

Shelf life: 3 years

Other substances similar to hydroxyethyl starch + sodium acetate trihydrate + sodium chloride + potassium chloride + magnesium chloride hexahydrate